Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AD/PD 2021 | The influence of the gut microbiome on amyloid-beta

Sangram Sisodia, PhD, University of Chicago, Chicago, IL, describes research evaluating the influence of the gut microbiome on the modulation of neuroinflammation and amyloid-beta deposition in Alzheimer’s disease. It has been demonstrated, in mouse models, that antibody treatments that alters the composition of the microbiota result in reduced amyloid-beta plaque burden in males although interestingly, not females. Future research which will involve fecal transplantation experiments in germ-free mice to better understand these sex-specific differences, the role of microglia and other underlying mechanisms, molecules and bacterial strains involved in this pathophysiological process. This interview took place during the AD/PD™ 2021 conference.

Choose your cookie settings

VJNeurology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.